Publications
Search our bibliography using the filters on the right-hand side.
Displaying 101 through 141 of 141 publications.
Skip to main content
Poulos C, Hauber AB, González JM, Turpcu A. Patients' willingness to trade off between the duration and frequency of rheumatoid arthritis treatments. Arthritis Care Res (Hoboken). 2014 Jul;66(7):1008-15. doi: 10.1002/acr.22265
Poulos C, Kinter E, Yang JC, Bridges JFP, Posner JD, Reder A. United States multiple sclerosis patients' preferences for injectable treatments. Poster presented at the European Federation of Neurological Sciences - European Neurological Society Joint Congress of European Neurology; May 31, 2014.
Yuan Z, Levitan B, Burton P, Poulos C, Hauber AB, Berlin JA. Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives. Curr Med Res Opin. 2014;30(9):1733-41.
Poulos C, González JM, Lee LJ, Boye KS, Johnson FR, Bae JP, Deeg MA. Physician preferences for extra-glycemic effects of type 2 diabetes treatments. Diabetes Ther. 2013 Dec;4(2):443-59. doi: 10.1007/s13300-013-0046-7.
Gonzalez JM, Johnson FR, Runken MC, Poulos CM. Evaluating migraineurs' preferences for migraine treatment outcomes using a choice experiment. Headache. 2013 Nov;53(10):1635-50.
Yuan Z, Levitan B, Burton P, Poulos C, Hauber AB, Berlin J. Relative importance of benefits and risks associated with antithrombotic therapies of acute coronary syndrome: patient and physician perspectives. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A292-3.
Kim D, Lauria DT, Poulos C, Dong B, Whittington D. Effect of travel distance on household demand for typhoid vaccines: implications for planning. Int J Health Plann Manage. 2013 Mar 12;Advance Online.
Poulos C, Hauber AB, Gonzalez JM, Ogale S, Turpcu A. Patient trade-offs between frequency and duration of biologic treatments for rheumatoid arthritis. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A42.
Poulos C, Hauber AB, Gonzalez JM, Ogale S, Turpcu A. Patient trade-offs between frequency and duration of biologic treatments for rheumatoid arthritis. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 6, 2012. [abstract] Value Health. 2012 Jun; 15(4):A42.
Gonzalez J, Johnson R, Runken MC, Poulos C. Generalized healthy-time equivalents for migraine-treatment outcomes from choice-experiment trade-off preferences. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011.
Poulos C, Yang JC, Levin C, Minh HV, Giang KB, Nguyen D. Mothers' preferences and willingness to pay for HPV vaccines in Vinh Long Province, Vietnam. Soc Sci Med. 2011 Jul 1;73(2):226-34.
Brown TM, Pashos CL, Joshi AV, Lee WC. The perspective of patients with haemophilia with inhibitors and their care givers: preferences for treatment characteristics. Haemophilia. 2011 May 1;17(3):476-82.
Poulos C, Riewpaiboon A, Stewart JF, Clemens J, Guh S, Agtini M, Anh DD, Baiqing D, Bhutta Z, Sur D, Whittington D. Cost of illness due to typhoid fever in five Asian countries. Trop Med Int Health. 2011 Mar 1;16(3):314-23.
Poulos C, Yang J, Patil SR, Pattanayak SK, Wood S, Goodyear L. Consumer preferences for household water treatment products in Andhra Pradesh, India: an application of choice-format conjoint analysis. Poster presented at the 3rd Biennial Conference of the American Society of Health Economists; June 2010.
Smith VK, Evans MF, Banzhaf HS, Poulos C. Can weak substitution be rehabilitated? Environ Resour Econ (Dordr). 2010 Feb 1;45(2):203-21.
Brown DS, Johnson FR, Poulos C, Messonnier ML. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine. 2010 Feb 1;28(7):1702-8.
Johnson FR, Hauber AB, Poulos CM. A brief introduction to the use of stated-choice methods to measure preferences for treatment benefits and risks. 2009. Research Triangle Park: RTI Press.
Pattanayak SK, Poulos C, Yang JC, Patil SR, Wendland KJ. Of taps and toilets: quasi-experimental protocol for evaluating community-demand-driven projects. J Water Health. 2009 Sep 1;7(3):434-51.
Lauria DT, Maskery B, Poulos C, Whittington D. An optimization model for reducing typhoid cases in developing countries without increasing public spending. Vaccine. 2009 Mar 4;27(10):1609-21.
Brown DS, Johnson FR, Poulos C, Gonzalez JM, Messonnier ML. Mother-daughter preference conflicts and willingness-to-pay for HPV vaccines. Poster presented at the 2nd Conjoint Analysis in Health Conference; March 1, 2009.
Whittington D, Sur D, Cook J, Chatterjee S, Maskery B, Lahiri M, Poulos C, Boral S, Nyamete A, Deen J, Ochiai L, Bhattacharya SK. Rethinking cholera and typhoid vaccination policies for the poor: private demand in Kolkata, India. World Dev. 2009 Feb 1;37(2):399-409.
Valdivia C, Poulos C. Factors affecting farm operators' interest in incorporating riparian buffers and forest farming practices in northeast and southeast Missouri. Agroforest Syst. 2009 Jan 1;75(1):61-71.
Vickers AD, Mellor P. Identifying click-throughs in choice-based conjoint studies. Presented at the Advanced Research Techniques Forum of the American Marketing Association; 2009.
Brown DS, Johnson FR, Poulos C, Messonier MM. Mother-daughter preferences & willingness to pay for HPV vaccination. Presented at the 2nd Vaccine Global Congress; December 2008.
Lee WC, Joshi AV, Brown TM, Pashos CL. Patient- and caregiver-reported preferences for characteristics of treatments for hemophilia patients with inhibitors. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 2008. Toronto, Canada. [abstract] Value Health. 2008 May; 11(3):A164-5.
Guh S, Chen XB, Poulos C, Qi Z, Cao JW, von Seidlein L, Chen JC, Wang XY, Xing ZC, Nyamete A, Clemens J, Whittington D. Comparison of cost-of-illness with willingness-to-pay estimates to avoid shigellosis: evidence from China. Health Policy Plan. 2008 Mar 1;23(2):125-36.
Andrews EB, Irish WD, Gilsenan AW, Campbell WH. Evaluation of therapeutic risk management programs. In: Hartzema AG, Tilson HH, Arnold Chan K, editors. Pharmacoepidemiology and therapeutic risk management. 1st ed. Cincinnati: United States. Harvey Whitney Books; 2008. p.637-52.
Evans ME, Poulos C, Smith VK. Individual preferences and household choices: the potential role of dependency relationships. Presented at the 2007 ASSA Conferences; January 2007. Previously presented at the National Center for Environmental Economics Workshop: Morbidity and Mortality: How do We Value the Risk of Illness and Death?.
Evans MF, Poulos C, Smith V. Individual preferences and household choices: the potential role of dependency relationships. Poster presented at the National Center for Environmental Economics Workshop: Morbidity and Mortality: How do We Value the Risk of Illness and Death?; April 2006.
Johnson FR, Mladsi DM, Sparrowhawk K. Conjoint analysis: application to global pricing and reimbursement strategy. Presented at the 2005 ISPOR 8th Annual European Congress; November 7, 2005. Florence, Italy.
Doward LC, McKenna SP, Meads DM, Kavyasiddhi D, Hampson NE, Mayo KW. The symptomatic, functional and quality of life impact of multiple sclerosis: report on a qualitative investigation of the patients' perspective. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A135.
Guh S, Poulos C. Comparison of cost-of-illness to willingness-to-pay to avoid an episode of shigellosis in a rural area of China. Poster presented at the 27th Annual APPAM Research Conference: Understanding and Informing Policy Design; November 2005.
Stevens KJ, Brazier JE, McKenna SP, Doward LC, Cork MJ. The development of a preference-based measure of health in children with atopic dermatitis. Br J Dermatol. 2005 Aug 1;153(2):372-7.
Lucero MA, Mladsi D, Mauskopf J. Communicating the value: developing messages for payers. Presented at the 2004 ISPOR 7th Annual European Congress; October 24, 2004. Hamburg, Germany.
Rothman KJ, Lanes S, Sacks ST. Measuring drug effects means getting a clearer signal. Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):527-8.
Vickers AD. Adapting market simulations from choice-based conjoint analysis to pharmaceutical scenarios. Presented at the Annual Sawtooth Software Conference; 2004.
Hill AR, Aspinall P, Armbrecht A, Lumsden C, Nelson P, Brice R, Vickers AD. Utilities for quality of life from time trade-off and conjoint analysis in age-related macular degeneration. Poster presented at the Heriott Watt University; 2004.
Doward LC, McKenna SP, Meads DM, Ratcliffe J, Whalley D, Langley PC. Investigation into the feasibility of deriving relative and absolute utility from the recurrent genital herpes quality of life questionnaire (RGHQOL). Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov; 5(6):573-4.
Hauber AB, Bala MV, Fehnel SE. Conducting cost-benefit and cost-utility analysis: a conjoint analysis approach. Presented at the Annual Meetings of the International Society of Pharmacoeconomics and Outcomes Research; May 2001.
Poulos C, Whittington D. Time preferences for life-saving programs: evidence from six less developed countries. Environ Sci Technol. 2000 Apr 15;34(8):1445-55.
Sculpher M, Palmer MK, Heyes AE. Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid. Pharmacoeconomics. 2000 Apr;17(4):361-70.